Catalyst Wire Dossier Catalyst Wire Dossier

AH-001

· AnHorn Medicines Co. Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AH-001, covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety, Tolerability and Pharmacokinetics of AH-001 Following Topical Single and Multiple Ascending Dose Administration [Phase 1]

See pricing